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mini-matrilysin, in living world: a revolutionary
conserved zinc-dependent proteolytic
domain- helix-loop-helix catalytic zinc
binding domain (ZBD)
Wei-Hsuan Yu1*, Po-Tsang Huang1,2, Kuo-Long Lou1,2,3,4, Shuan-Su C Yu1 and Chen Lin1Figure 1 Combination of 0.05% Triton and 0.2 mg/ml heparin give the optimal refolding activities to cleave the synthetic coumarin-
labelled peptide substrate, Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2. Panel A: Shows the refolded ZBD activities increased in dose-dependent
manner. In the absence of the refolding accessory factors, Triton X-100 and heparin. The significant reduced activities in the high-concentration
(> 100 μg/ml) was observed which could be due to autolysis. Panel B: Under 37°C incubation for 18 hours, Triton X-100 and heparin can prevent
the activity loss.(All experiments were repeated at two batch of purification and refolding preparation and data collected from a representative
experiments).
There is a major mistake in the order of Figure 5 to Figure 7 in [1]. We replace the Figure 5 and Figure 6 in [1] with new
corrected Figures of Figure 1 and Figure 2. We also replace the correct original order of Figure 6 and Figure 7 in [1] with
Figure 2 and Figure 3 in this correction. Sorry for the inconveniences!* Correspondence: whyu2004@ntu.edu.tw
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Figure 2 The polymerization of the 6 kDa ZBD of MMP-7 in
pentomer and Octmer demonstrate the significant proteolytic
activities towards to the CM-transferrin substrate in
CM-transferrin zymographic assay. 300 μg of craboxylmethylated
transferrin (CM-transferrin) was co-polymerized with SDS-PAGE as a
substrate gel for analyzing the MMP-7 activities in situ.
Figure 3 Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 assay for characteriz
refolded ZBD shows increasing enzymatic activity in dose-dependent mann
situation. Panel B: approximately 6 ng/ml refolded ZBD shows the increasin
during overnight incubation. Panel C: Recombinant ZBD can be inhibited b
SC44463 and CoCl2, but not b6 250 nM Phosphoramidon. (All experiments
and data collected from a representative experiments).
Yu et al. Journal of Biomedical Science 2012, 19:87 Page 2 of 2
http://www.jbiomedsci.com/content/19/1/87Author details
1Institute of Biochemistry and Molecular Biology, National Taiwan University,
College of Medicine, Ren-Ai Road, Taipei, Taiwan. 2Graduate Institute of Oral
Biology, National Taiwan University, College of Medicine, Ren-Ai Road, Taipei,
Taiwan. 3NTU-DRCP Lectures and Core for Membrane Proteins, Center for
Biotechnology, National Taiwan University, Chang Sing Street, Taipei, Taiwan.
4Institute of Biotechnology, National Taiwan University, Chang Sing Street,
Taipei, Taiwan.
Received: 17 September 2012 Accepted: 24 September 2012
Published: 6 October 2012
Reference
1. Yu WH, Huang PT, Lou KL, Yu SS, Lin C: A Smallest 6 kDa Metalloprotease,
Mini-matrilysin, in Living World: a Revolutionary Conserved Zinc-
Dependent Proteolytic Domain- Helix-Loop-Helix Catalytic Zinc Binding
Domain (ZBD). J Biomed Sci 2012, 19:54.
doi:10.1186/1423-0127-19-87
Cite this article as: Yu et al.: Correction: A smallest 6 kda
metalloprotease, mini-matrilysin, in living world: a revolutionary
conserved zinc-dependent proteolytic domain- helix-loop-helix catalytic
zinc binding domain (ZBD). Journal of Biomedical Science 2012 19:87.ation of refolded ZBD. Panel A: Under the optimized conditions, the
er. No significant activity loss was found in the high concentration
g activity during the time course study and no significant activity loss
y 10 nM EDTA, 1 mM CoCl2 and synthetic inhibitors, 50 nM BB94 &
were repeated at two batch of purification and refolding preparation
